Cargando…

Molecular predictors of response to pembrolizumab in thymic carcinoma

Thymic carcinoma is rare and has a poorer prognosis than thymomas. The treatment options are limited after failure of platinum-based chemotherapy. We previously performed a single-center phase II study of pembrolizumab in patients with advanced thymic carcinoma, showing a 22.5% response rate. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yongfeng, Ramesh, Archana, Gusev, Yuriy, Bhuvaneshwar, Krithika, Giaccone, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484507/ https://www.ncbi.nlm.nih.gov/pubmed/34622229 http://dx.doi.org/10.1016/j.xcrm.2021.100392

Ejemplares similares

viGEN: An Open Source Pipeline for the Detection and Quantification of Viral RNA in Human Tumors
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2018)

Metabolomic and exome sequence analysis reveal novel molecular signatures associated with colorectal cancer relapse
por: Gauba, Robinder, et al.
Publicado: (2012)

Novel Treatments for Thymoma and Thymic Carcinoma
por: Rajan, Arun, et al.
Publicado: (2015)

The REMBRANDT study, a large collection of genomic data from brain cancer patients
por: Gusev, Yuriy, et al.
Publicado: (2018)

In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers
por: Gusev, Yuriy, et al.
Publicado: (2013)

CINdex: A Bioconductor Package for Analysis of Chromosome Instability in DNA Copy Number Data
por: Song, Lei, et al.
Publicado: (2017)

SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma
por: Lin, Ling, et al.
Publicado: (2021)

Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma
por: Russ, Eric, et al.
Publicado: (2021)

Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2019)

Best practices and guidelines for the management of thymic epithelial tumors
por: Giaccone, Giuseppe, et al.
Publicado: (2019)

A case study for cloud based high throughput analysis of NGS data using the globus genomics system
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2014)

Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features
por: Sayah, Anousheh, et al.
Publicado: (2022)

Author Correction: Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features
por: Sayah, Anousheh, et al.
Publicado: (2022)

Mutations of epigenetic regulatory genes are common in thymic carcinomas
por: Wang, Yisong, et al.
Publicado: (2014)

Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression
por: Isshiki, Takuma, et al.
Publicado: (2018)

Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report
por: Nishii, Yoichi, et al.
Publicado: (2022)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

G-DOC Plus – an integrative bioinformatics platform for precision medicine
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2016)

Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in two patients with metastatic thymic squamous cell carcinoma: Case report
por: Chen, Cui, et al.
Publicado: (2022)

Metastatic Hepatocellular Carcinoma Responsive to Pembrolizumab
por: Truong, Phu, et al.
Publicado: (2016)

EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2017)

Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review
por: Cafaro, Alessandro, et al.
Publicado: (2020)

Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report
por: Wong-Chong, Jonathan, et al.
Publicado: (2021)

Molecular Farming of Pembrolizumab and Nivolumab
por: Stark, Michael C., et al.
Publicado: (2023)

Metronomics for thymic carcinoma
por: del Toro, Jacobo Muñoz, et al.
Publicado: (2014)

Complete response to pembrolizumab in recurrent nested variant of urothelial carcinoma
por: Fukuta, Kyotaro, et al.
Publicado: (2021)

Hepatoid thymic carcinoma: a case report of a rare subtype of thymic carcinoma
por: Jeong, Ji-Seon, et al.
Publicado: (2021)

Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
por: van Baar, Mireille L.M., et al.
Publicado: (2019)

The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma
por: Li, Huiyang, et al.
Publicado: (2023)

AIRE illuminates the feature of medullary thymic epithelial cells in thymic carcinoma
por: Matsumoto, Minoru, et al.
Publicado: (2023)

Diagnostic Roles of Immunohistochemistry in Thymic Tumors: Differentiation between Thymic Carcinoma and Thymoma
por: Jeong, Jae-Han, et al.
Publicado: (2020)

Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States
por: Hsu, Chun-Hsiang, et al.
Publicado: (2019)

Thymic Carcinoma: A Review
por: Alqaidy, Doaa, et al.
Publicado: (2022)

Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
por: Chang, Hao‐Chun, et al.
Publicado: (2020)

Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane
por: Alam, Walid, et al.
Publicado: (2021)

Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab
por: Mizushina, Yoshiko, et al.
Publicado: (2021)

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
por: Kadota, Naoki, et al.
Publicado: (2021)

Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer
por: Mimura, Kaito, et al.
Publicado: (2022)

Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
por: Domingo-Musibay, Evidio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d6d35jilrs1on9raeote3d8glb